126 related articles for article (PubMed ID: 8870813)
1. Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.
Fernández-Castañer M; Camps I; Fernández-Real JM; Domenech P; Martínez-Brotons F
Acta Diabetol; 1996 Jul; 33(2):118-21. PubMed ID: 8870813
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis and fibrinolysis factors in first-degree relatives of patients with Type 2 diabetes without hypertension.
Trifiletti A; Lasco A; Scamardi R; Cincotta M; Gaudio A; Barbera N; Frisina N
Pathophysiol Haemost Thromb; 2002; 32(3):127-30. PubMed ID: 12372926
[TBL] [Abstract][Full Text] [Related]
3. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
[TBL] [Abstract][Full Text] [Related]
4. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.
Ceriello A; Taboga C; Tonutti L; Giacomello R; Stel L; Motz E; Pirisi M
Diabetologia; 1996 Apr; 39(4):469-73. PubMed ID: 8777997
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
6. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
Fernández-Castañer M; Biarnés J; Camps I; Ripollés J; Gómez N; Soler J
Diabet Med; 1996 Nov; 13(11):953-9. PubMed ID: 8946153
[TBL] [Abstract][Full Text] [Related]
8. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
9. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
[TBL] [Abstract][Full Text] [Related]
10. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
11. Protein C activation in NIDDM patients.
Gabazza EC; Takeya H; Deguchi H; Sumida Y; Taguchi O; Murata K; Nakatani K; Yano Y; Mohri M; Sata M; Shima T; Nishioka J; Suzuki K
Diabetologia; 1996 Dec; 39(12):1455-61. PubMed ID: 8960826
[TBL] [Abstract][Full Text] [Related]
12. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
13. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Ceriello A; Bortolotti N; Pirisi M; Crescentini A; Tonutti L; Motz E; Russo A; Giacomello R; Stel G; Taboga C
Diabetes Care; 1997 Oct; 20(10):1589-93. PubMed ID: 9314640
[TBL] [Abstract][Full Text] [Related]
14. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects.
Beer SF; O'Rahilly S; Spivey RS; Hales CN; Turner RC
Diabetes Res; 1990 Jun; 14(2):51-4. PubMed ID: 2134213
[TBL] [Abstract][Full Text] [Related]
15. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
[TBL] [Abstract][Full Text] [Related]
16. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
18. Glucose tolerance in rural diabetic Thais, first-degree relatives and non-diabetic controls.
Davis TM; Pramukkul P; Suputtamongkol Y; Chaowagul W; Levy J
Diabetes Res Clin Pract; 1995 Mar; 27(3):171-80. PubMed ID: 7555598
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
